VEGF-A Inhibition Ameliorates Podocyte Apoptosis via Repression of Activating Protein 1 in Diabetes

No abstract is available for this paper.

• Publication year

  2015

• Venue

  American Journal of Nephrology

• Publication date

  2015-01-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000369942PMID 25572464
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• GIV/girdin links vascular endothelial growth factor signaling to Akt survival signaling in podocytes independent of nephrin.

  2015cited by this paper
• Podocyte-specific RAP1GAP expression contributes to focal segmental glomerulosclerosis-associated glomerular injury.

  2014cited by this paper
• Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis.

  2014cited by this paper
• Antiangiogenic Treatment Diminishes Renal Injury and Dysfunction via Regulation of Local AKT in Early Experimental Diabetes

  2014cited by this paper
• Vascular Endothelial Growth Factor-Receptor 1 Inhibition Aggravates Diabetic Nephropathy through eNOS Signaling Pathway in db/db Mice

  2014cited by this paper
• Ubiquitination-dependent CARM1 degradation facilitates Notch1-mediated podocyte apoptosis in diabetic nephropathy.

  2014cited by this paper
• Cooperative Signaling via Transcription Factors NF-κB and AP1/c-Fos Mediates Endothelial Cell STIM1 Expression and Hyperpermeability in Response to Endotoxin*

  2014cited by this paper
• Down-Regulation of PERK-ATF4-CHOP Pathway by Astragaloside IV is Associated with the Inhibition of Endoplasmic Reticulum Stress-Induced Podocyte Apoptosis in Diabetic Rats

  2014cited by this paper
• Podocytes, signaling pathways, and vascular factors in diabetic kidney disease.

  2014cited by this paper
• Resistin derived from diabetic perivascular adipose tissue up-regulates vascular expression of osteopontin via the AP-1 signalling pathway

  2013cited by this paper
• The expression of glutamate aspartate transporter (GLAST) within the human cochlea and its distribution in various patient populations.

  2013cited by this paper
• Vegfa Protects the Glomerular Microvasculature in Diabetes

  2012cited by this paper
• Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma

  2012cited by this paper
• AP-1 Transcription Factor JunD Confers Protection from Accelerated Nephrotoxic Nephritis and Control Podocyte-Specific Vegfa Expression

  2011cited by this paper
• IKKα contributes to UVB-induced VEGF expression by regulating AP-1 transactivation

  2011cited by this paper
• Induction of Podocyte-Derived VEGF Ameliorates Podocyte Injury and Subsequent Abnormal Glomerular Development Caused by Puromycin Aminonucleoside

  2011cited by this paper
• Vascular Endothelial Growth Factor Receptor 2 Direct Interaction with Nephrin Links VEGF-A Signals to Actin in Kidney Podocytes*

  2011cited by this paper
• Podocyte Number in the Maturing Rat Kidney

  2010cited by this paper
• The balance of autocrine VEGF-A and VEGF-C determines podocyte survival.

  2009cited by this paper
• Inducible Overexpression of sFlt-1 in Podocytes Ameliorates Glomerulopathy in Diabetic Mice

  2008cited by this paper
• Apoptosis in the kidneys of patients with type II diabetic nephropathy.

  2007cited by this paper
• Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.

  2006cited by this paper
• Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice.

  2006cited by this paper
• Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man.

  2006cited by this paper
• Blockade of VEGF accelerates proteinuria, via decrease in nephrin expression in rat crescentic glomerulonephritis.

  2006cited by this paper
• Inhibition of Vascular Endothelial Growth Factor (VEGF) Does Not Affect Early Renal Changes in a Rat Model of Lean Type 2 Diabetes

  2005cited by this paper
• Human Bcl-2 activates ERK signaling pathway to regulate activating protein-1, lens epithelium-derived growth factor and downstream genes

  2004cited by this paper
• Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy.

  2004cited by this paper
• Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases.

  2003cited by this paper
• A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression.

  2002cited by this paper
• Regulation of Vascular Endothelial Growth Factor Expression in Human Keratinocytes by Retinoids*

  2000cited by this paper
• The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing.

  1991cited by this paper

• Integrating UHPLC-QE-MS and Bioinformatics with Experimental Validation Reveals MAPK/FOS-Mediated Podocyte Apoptosis as the Key Mechanism of Alpiniae oxyphyllae and Saposhnikovia divaricata in Treating Diabetic Kidney Disease

  2025cites this paper
• Stem cell-derived exosomal MicroRNAs: Potential therapies in diabetic kidney disease.

  2023cites this paper
• Paeoniflorin binds to VEGFR2 to restore autophagy and inhibit apoptosis for podocyte protection in diabetic kidney disease through PI3K-AKT signaling pathway.

  2022cites this paper
• miR-222 regulates cell growth, apoptosis, and autophagy of interstitial cells of Cajal isolated from slow transit constipation rats by targeting c-kit

  2021cites this paper
• Glomerular Endothelial Cell Crosstalk With Podocytes in Diabetic Kidney Disease

  2021cites this paper
• Research Progress on the Pathological Mechanisms of Podocytes in Diabetic Nephropathy

  2020cites this paper
• Advanced Oxidation Protein Products Aggravate Tubulointerstitial Fibrosis Through Protein Kinase C-Dependent Mitochondrial Injury in Early Diabetic Nephropathy

  2019cites this paper
• Research Themes and Trends in Ten Top-Ranked Nephrology Journals: A Text Mining Analysis

  2019cites this paper
• Pathogenesis of Fabry nephropathy: The pathways leading to fibrosis.

  2019cites this paper
• Modulation of vascular endothelial growth factor and mitogen‐activated protein kinase‐related pathway involved in extracorporeal shockwave therapy accelerate diabetic wound healing

  2018cites this paper
• VEGFA Involves in the Use of Fluvastatin and Zoledronate Against Breast Cancer

  2018cites this paper
• Long Noncoding RNA LINC01619 Regulates MicroRNA-27a/Forkhead Box Protein O1 and Endoplasmic Reticulum Stress-Mediated Podocyte Injury in Diabetic Nephropathy

  2018cites this paper
• Silencing of c-jun decreases cell migration, invasion, and EMT in radioresistant human nasopharyngeal carcinoma cell line CNE-2R

  2018cites this paper
• WT1 ameliorates podocyte injury via repression of EZH2/&bgr;‐catenin pathway in diabetic nephropathy

  2017cites this paper
• MicroRNA-27a promotes podocyte injury via PPARγ-mediated β-catenin activation in diabetic nephropathy

  2017cites this paper
• CDK5 promotes renal tubulointerstitial fibrosis in diabetic nephropathy via ERK1/2/PPARγ pathway

  2016cites this paper
• MicroRNA-130b promotes lung cancer progression via PPARγ/VEGF-A/BCL-2-mediated suppression of apoptosis

  2016cites this paper
• MicroRNA-27a promotes renal tubulointerstitial fibrosis via suppressing PPARγ pathway in diabetic nephropathy

  2016cites this paper
• Glomerular cell crosstalk

  2016cites this paper
• In silico analysis for association of hyperthermia and tumorigenesis

  2015cites this paper
• MicroRNA-130b improves renal tubulointerstitial fibrosis via repression of Snail-induced epithelial-mesenchymal transition in diabetic nephropathy

  2015cites this paper